Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2023-01-11 00:00:00 ET · period of report 2023-01-09 · accession 0001334549-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-11 | 2023-01-09+ | LSTA | Mazzo David J | CEO, Dir | F - Tax | $3.06 | -11.3K | 98.0K | -10% | -$34.6K |
| D | 2023-01-11 | 2023-01-09 | LSTA | Mazzo David J | CEO, Dir | A - Grant | $0.00 | +60.0K | 109.3K | +122% | $0 |
| D | 2023-01-11 | 2023-01-09 | LSTA | Mazzo David J | CEO, Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-09 | F | D | 7,845 | $3.00 | 101,440 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 69,783 unvested restricted stock. |
| 2 | Common | Common Stock | 2023-01-09 | A | A | 60,000 | $0.00 | 109,285 | D | — | — | (F1) Represents 60,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. (F2) Includes 69,783 unvested restricted stock. |
| 3 | Common | Common Stock | 2023-01-10 | F | D | 3,470 | $3.20 | 97,970 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F4) Includes 63,100 unvested restricted stock. |
| 4 | Derivative | Stock Options (Right to Buy) | 2023-01-09 | A | A | 30,000 | $0.00 | 30,000 | D | $3.00 · 2023-01-09 to 2033-01-09 | 30,000 Common Stock | (F5) One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. |